Symbols

How does LEXX's Q1 2024 EPS performance compare to previous quarters?

4/12/2025 10:29am

Aime

Lexaria Bioscience's Q1 2024 EPS performance shows a decline compared to the previous quarter. The company reported an EPS of -$0.13 for Q1 2024, while the previous quarter's EPS was not available. However, the previous quarter's EPS was not significantly better, with the EPS being -$0.15¹. This indicates a slight improvement in EPS performance from the previous quarter to Q1 2024.

LEXX Diluted EPS YoY, Diluted EPS

Source:

a

1. Lexaria Bioscience (NASDAQ:LEXX) Price Target Raised to $12.00 at Maxim Group